Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: Specific increase in interleukin-6 mRNA expression

Journal of Neurochemistry

Volumn 72, Issue 6, 1999, Pages 2426-2436

  Sayah, Sakina ^a   Ischenko, Alexander M ^b   Zhakhov, Alexander ^b   Bonnard, Anne Sophie ^a   Fontaine, Marc ^a  

^a INSERM   (France)

^b State Research Institute of Highly Pure Biopreparations   (Russian Federation)

Author keywords

Anaphylatoxin; Astrocytes; Brain; Complement; Cytokines; Inflammation

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYTOKINE; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; ASTROCYTOMA; COMPLEMENT ACTIVATION; ENCEPHALITIS; ENZYME RELEASE; HUMAN; HUMAN CELL; MAST CELL DEGRANULATION; PEPTIDE SYNTHESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR BLOCKING;

ANAPHYLATOXINS; ANTIBODIES; ANTIGENS, CD; ASTROCYTOMA; COMPLEMENT C3A; COMPLEMENT C5A; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; MEMBRANE PROTEINS; PERTUSSIS TOXIN; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0033011634     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722426.x     Document Type: Article

References (42)

1. Ames R. S., Li Y., Sarau H. M., Nuthulaganti P., Foley J. J., Ellis C., Zeng Z., Su K., Jurewicz A. J., Hertzberg R. P., Bergsma D. J., and Kumar C. (1996) Molecular cloning and characterisation of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271, 20231-20234.
2. Arend W. P., Massoni R. J., Nieman M. A., and Giclas P. C. (1989) Absence of induction of IL-1 production in human monocytes by complement fragments. J. Immunol. 142, 173-178.
3. Bischoff S. C., Deweck A. L., and Dahinden C. A. (1990) Interleukin-3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc. Natl Acad. Sci. USA 87, 6813-6817.
4. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., and Cerami A. (1986) Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83, 1670-1674.
5. Compston D. A. S., Morgan B. P., Campbell A. K., Wilkins P., Dole G., Thomas N. D., and Jasani B. (1989) Immunocytochemical localisation of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15, 307-316.
6. Crass T., Raffetseder U., Martin U., Grove M., Klos A., Köhl J., and Bautsch W. (1996) Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U937 cells. Eur. J. Immunol. 26, 1944-1950.
7. Foreman K. E., Vaporciyan A. A., Bonish B. K., Jones M. L., Glovsky M. M., Eddy S. M., and Ward P. (1994) C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94, 1147-1150.
8. Frank M. M. and Fries L. F. (1991) Complement interactions and functions: the role of complement in inflammation and phagocytosis. Immunol. Today 12, 322-326.
9. Gadient R. A. and Otten U. H. (1997) Interleukin-6 (IL-6), a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52, 379-390.
10. Gasque P., Julen N., Ischenko A., Picot C., Mauger C., Chauzy C., Ripoche J., and Fontaine M. (1992) Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149, 1381-1387.
11. Gasque P., Ischenko A., Legoedec J., Mauger C., Schouft M. T., and Fontaine M. (1993) Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells. J. Biol. Chem. 268, 25068-25074.
12. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Götze O., and Morgan B. P. (1995a) Identification and characterisation of the complement C5a anaphylatoxin receptor on human astrocytes: relevance to inflammation in the brain. J. Immunol. 155, 4882-4889.
13. Gasque P., Fontaine M., and Morgan B. P. (1995b) Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154, 4726-4733.
14. Gasque P., Singhrao S. K., Neal J. W., Wang P., Sayah S., Fontaine M., and Morgan B. P. (1998) The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J. Immunol. 160, 3543-3554.
15. Gerard N. P. and Gerard C. (1991) The chemotactic receptor for C5a anaphylatoxin. Nature 349, 614-617.
16. Goodman M. G., Chenoweh D. E., and Weigle W. O. (1982) Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophages surface C5a receptors. J. Exp. Med. 156, 912-917.
17. Haeffner-Cavaillon N., Cavaillon J. M., Laude M., and Kazatchkine M. D. (1987) C3a (C3adesarg) induces production and release of interleukin-1 by cultured human monocytes. J. Immunol. 139, 794-799.
18. Haviland D. L., MacCoy R. L., Whitehead W. T., Akama H., Molmenti E. P., Brown A., Haviland J. C., Parks W. C., Perlmutter D. H., and Wetsel R. A. (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154, 1861-1869.
19. Ischenko A. M., Sayah S., Patte C., Andreev S., Gasque P., Schouft M.-T., Vaudry H., and Fontaine M. (1998) Expression of a functional anaphylatoxin C3a receptor by astrocytes. J. Neurochem. 71, 2487-2496.
20. Johnson S. A., Lampert-Etchells M., Pasinetti G. M., Rozovsky I., and Finch C. E. (1992) Complement mRNAs in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13, 641-648.
21. Kaspar R. L. and Gehrke L. (1994) Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1β mRNA show unequal IL-1β protein accumulation but similar polyribosome profiles. J. Immunol. 153, 277-286.
22. Linington C., Morgan B. P., Scolding N. J., Piddlesden S., Wilkins P., and Compston D. A. S. (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112, 895-911.
23. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S. D., Ohtsuki T., Kinoshita T., Kamada T., and Stern D. M. (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival. J. Exp. Med. 180, 2297-2308.
24. Maimone D., Guazzi G. C., and Annunziata P. (1996) IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 146, 59-65.
25. Malter J. S. (1989) Identification of an AUUUA-speciflc messenger RNA binding protein. Science 246, 664-668.
26. McGeer E. G. and McGeer P. L. (1997) Inflammatory cytokines in the CNS. Possible role in the pathogenesis of neurodegenerative disorders and therapeutic implications. Pharmacol. Pathophysiol. 3, 214-228.
27. 2+ influx in neutrophils via a pertussis-toxin sensitive G protein. Eur. J. Biochem. 217, 289-294.
28. Pasinetti G. M. Johnson S. A., Rozovski I., Lampert-Etchells M., Morgan D. G., Gordon M. N., Morgan T. E., Willoughby D., and Finch C. E. (1992) Complement C1q and C4 mRNA responses to lesioning in rat brain. Exp. Neurol. 118, 117-125.
29. Piddlesden S. J. and Morgan B. P. (1993) Killing rat glial cells by complement components: deficiency of the rat analogue CD59 is the cause of oligodendrocyte susceptibility to lysis. J. Neuroimmunol. 48, 169-176.
30. Piddlesden S. J., Storch M. K., Hibbs M., Freeman A. M., Lassman H., and Morgan B. P. (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. immunol. 152, 5477-5484.
31. Rogers J., Cooper N. R., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P., and Lieberburg I. (1992) Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89, 10016-10020.
32. Roglic A., Prossnitz E. R., Cavanagh S. L., Pan Z., Zou A., and Ye R. D. (1996) cDNA cloning of a novel G-protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta 1305, 39-43.
33. 1 complex. Proc. Natl. Acad. Sci. USA 88, 971-975.
34. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning, A Laboratory Manual, 2nd edit., pp. 7.19-7.22. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
35. Sayah S., Patte C., Gasque P., Chan P., Ischenko A., Vaudry H., and Fontaine M. (1997) Characterisation of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Mol. Brain Res. 48, 215-222.
36. Sayah S., Leon P., Chan P., and Fontaine M. (1998) C3a and C5a anaphylatoxin receptors. Med. Sci. 14, 291-299.
37. Schindler R., Gelfand J. A., and Dinarello C. A. (1990) Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal pro-vided by lipopolysaccharide or IL-1. Blood 76, 1631-1638.
38. Takabayashi T., Vannier E., Clark B. D., Margolis N. H., Dinarello C. A., Burke J. F., and Gelfand J. A. (1996) A new biological role for C3a and C3a desarg. Regulation of TNF-α and IL-1β synthesis. J. Immunol. 156, 3455-3460.
39. Tonouchi N., Miwa K., Karasuyama H., and Matsui H. (1989) Deletion of the 3′-untranslated region of human BSF-2 mRNA causes stabilisation of the mRNA and high-level expression in mouse NIH-3T3 cells. Biochem. Biophys. Res. Commun. 163, 1056-1062.
40. Walker D. G. and McGeer P. L. (1992) Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14, 109-116.
41. Werfel T., Zwirner J., Opperman M., Sieber A., Begeman G., Drommer W., Kapp A., and Götze O. (1996) CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin. J. Immunol. 157, 1729-1735.
42. Wren D. R. and Noble M. (1989) Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc. Natl. Acad. Sci. USA 86, 9025-9029.